Brentuximab vedotin (solution), CAS [[914088-09-8]]
Artikelnummer:
MCE-HY-P99107A
Hersteller Artikelnummer:
HY-P99107A
Alternativnummer:
MCE-HY-P99107A-1MG,MCE-HY-P99107A-5MG
Hersteller:
MedchemExpress
Kategorie:
Biochemikalien
Brentuximab vedotin (solution) (cAC10-vcMMAE) is an antibody-drug conjugate (ADC) comprising an anti-CD30 antibody and the cytotoxic agent Monomethyl auristatin E (MMAE). The antibody portion is Brentuximab (HY-P99151), and the drug-linker conjugate for ADC is VcMMAE (HY-15575). Brentuximab vedotin (solution) inhibits CD30-positive cells with an IC50 of 2.5 ng/mL. Brentuximab vedotin (solution) can be used for the research of relapsed and refractory Hodgkin lymphoma[1][2].
Molekulargewicht:
153000 (average)
Reinheit:
99.73
CAS Nummer:
[914088-09-8]
Target-Kategorie:
Antibody-Drug Conjugates (ADCs),Apoptosis
Anwendungsbeschreibung:
MCE Product type: ADC Related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
